← ANALYST RATINGS · TIPRANKS
Henry Schein (HSIC): analyst forecast and price target
Analyst consensus
Moderate Buy5 Buy3 Hold1 Sell
Ratings of 9 analysts in the last 3 months · top analysts only12-month forecast
Based on 9 price targets given in the last 3 months, the average target is $97.00, the highest $110, the lowest $64.00. The average is +12.3% from the last price of $86.38.
Analyst ratings 17
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Michael Cherny★★★★★★★★★★#2074 · hits 57% · avg +5.7% | Leerink Partners | $96.00 → $92.00−4.2% | Hold | +6.5% | Reiterated | 14.10.26on TipRanks 08:55 | +1.7%next day +1.4% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $64.00 | Sell | −25.9% | Assigned | 12.10.26on TipRanks 08:15 | +0.3%next day +1.0% | ↗ |
| Jeff Johnson★★★★★★★★★★#1125 · hits 51% · avg +10.4% | Robert W. Baird | $109 | Buy | +26.2% | Reiterated | 09.10.26on TipRanks 08:50 | −1.3%next day +0.3% · 5 days +4.8% | ↗ |
| Michael Petusky★★★★★★★★★★#4246 · hits 45% · avg +2.3% | Barrington | $104 | Buy | +20.4% | Reiterated | 09.10.26on TipRanks 07:50 | −1.3%next day +0.3% · 5 days +4.8% | ↗ |
| AI DeepSeek Medical - DistributionDeepSeek R1-0528 | TipRanks - DeepSeek | $88.00 → $86.00−2.3% | Hold | −0.4% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI OpenAI Medical - DistributionOpenAI 4o | TipRanks - OpenAI | $91.00 → $88.00−3.3% | Hold | +1.9% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI Anthropic Medical - DistributionAnthropic Opus-4.1 | TipRanks - Anthropic | $86.00 → $84.00−2.3% | Hold | −2.8% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI Google Medical - DistributionGemini 2.5Pro | TipRanks - Google | $92.00 → $88.00−4.3% | Hold | +1.9% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI PerPlexity Medical - DistributionPerPlexity SonarPro | TipRanks - PerPlexity | $91.00 → $89.00−2.2% | Hold | +3.0% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% | Bank of America Securities | $90.00 → $110+22.2% | Buy | +27.3% | Reiterated | 07.10.26on TipRanks 06:50 | −1.2%next day +1.6% · 5 days +3.3% | ↗ |
| AI xAi Medical - DistributionxAI Grok-3 | TipRanks - xAI | $98.00 → $87.00−11.2% | Hold | +0.7% | Reiterated | 22.09.26on TipRanks 14:05 | — | |
| Jason Bednar★★★★★★★★★★#11450 · hits 46% · avg −2.5% | Piper Sandler | $95.00 → $104+9.5% | Buy | +20.4% | Reiterated | 18.09.26on TipRanks 07:45 | −0.4%next day −1.1% · 5 days +0.5% | ↗ |
| David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% | BTIG | $100 → $110+10.0% | Buy | +27.3% | Reiterated | 19.08.26on TipRanks 07:30 | −0.1%next day −0.1% · 5 days +1.6% | ↗ |
| John Stansel★★★★★★★★★★#9374 · hits 46% · avg −2.3% | J.P. Morgan | $102 | Buy | +18.1% | Reiterated | 06.08.26on TipRanks Aug 7 08:10 | −1.4%next day −0.7% · 5 days +0.9% | ↗ |
| Steven Valiquette★★★★★★★★★★#8240 · hits 53% · avg 0.0% | Mizuho Securities | $82.00 → $86.00+4.9% | Hold | −0.4% | Reiterated | 05.08.26on TipRanks 07:35 | +0.7%next day −1.4% · 5 days +0.9% | ↗ |
| Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% | UBS | $89.00 → $94.00+5.6% | Hold | +8.8% | Reiterated | 05.08.26on TipRanks 07:25 | +0.7%next day −1.4% · 5 days +0.9% | ↗ |
| Jonathan Block★★★★★★★★★★#2320 · hits 50% · avg +5.3% | Stifel Nicolaus | $84.00 → $95.00+13.1% | Hold | +10.0% | Reiterated | 05.08.26on TipRanks 07:15 | +0.7%next day −1.4% · 5 days +0.9% | ↗ |
| Daniel Grosslight★★★★★★★★★★#4007 · hits 47% · avg +3.6% | Citi | $100 → $112+12.0% | Buy | +29.7% | Reiterated | 05.08.26on TipRanks 06:40 | +0.7%next day −1.4% · 5 days +0.9% | ↗ |
| Glen Santangelo★★★★★★★★★★#2956 · hits 52% · avg +4.5% | Barclays | $86.00 → $100+16.3% | Buy | +15.8% | Reiterated | 05.08.26on TipRanks 04:13 | +0.7%next day −1.4% · 5 days +0.9% | ↗ |
| Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% | BMO Capital | $85.00 | Hold | −1.6% | Reiterated | 04.08.26on TipRanks Aug 5 07:30 | +1.2%next day +0.7% · 5 days +0.2% | ↗ |
| Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% | William Blair | — | Hold | — | Reiterated | 04.08.26on TipRanks 10:33 | +1.2%next day +0.7% · 5 days +0.2% | ↗ |
| Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% | Evercore ISI | $90.00 → $105+16.7% | Buy | +21.6% | Reiterated | 04.08.26on TipRanks 10:33 | +1.2%next day +0.7% · 5 days +0.2% | ↗ |
| Unknown Analyst | Wells Fargo | $76.00 → $87.00+14.5% | Hold | +0.7% | Reiterated | 25.02.26on TipRanks 07:40 | −2.6%next day 0.0% · 5 days −0.5% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Henry Schein
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $101 at a price of $83.97 (+20.6%); now: $98.13 at $86.38 (+13.6%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 8 | 6 | 6 | 5 | 6 | 9 |
| Hold | 2 | 2 | 3 | 3 | 3 | 4 |
| Sell | 2 | 2 | 1 | 0 | 0 | 1 |
Earnings and sales forecast
Next report: 03.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.36 (from $1.30 to $1.45). Last quarter: $1.27.
Sales
Next quarter’s sales estimate — $3.5B (from $3.4B to $3.5B). Last quarter: $3.5B.
Best top-analyst consensus in the sector · Healthcare
About Henry Schein
- CEO: Frederick Lowery
- Employees: 25,000
- 135 Duryea Road, Melville, NY, 11747, US
- www.henryschein.com
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Data from the stock’s TipRanks forecast page, read 20 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗